Percutaneous Coronary Interventions with Drug-eluting Balloons: Croatian Experience.

Drug-eluting balloons for percutaneous coronary interventions.

Thromb Haemost 2009; 101: 9–11 The simple and originally naïve idea of dilating a coronary stenosis to restore unobstructed coronary flow through percutaneous transluminal coronary angioplasty (PTCA) (1) has been a major advance in the treatment of acute coronary syndromes and is currently also commonly used in stable coronary artery disease (2). However, there is no such thing as a “free lunch...

Drug eluting balloon versus drug eluting stent in percutaneous coronary interventions: insights from a meta-analysis of 1462 patients.

BACKGROUND Drug eluting balloons (DEB) have been developed to overcome the limitations of drug eluting stents (DES), but clinic results of various DEB studies are still not consistent. Thus, we performed a meta-analysis to compare outcomes of DEB and DES for the treatment of coronary artery disease (CAD). METHODS Medline/Web databases were searched for studies comparing DEB and DES for obstru...

Primary Percutaneous Coronary Intervention With Drug-Eluting Stents

Primary percutaneous coronary intervention (P-PCI) is the preferred reperfusion strategy for patients with STsegment elevation myocardial infarction if it can be performed rapidly by an experienced team.1 Compared with balloon angioplasty, routine bare-metal stent (BMS) implantation decreases risk for target vessel revascularization (TVR) and possibly reduces myocardial reinfarction rates but d...

One-year clinical outcomes of percutaneous treatment with drug-eluting balloons: results from a multicenter registry.

INTRODUCTION AND OBJECTIVES Percutaneous coronary intervention (PCI) with paclitaxel drug-eluting balloons (DEBs) is used mainly for treatment of in-stent restenosis (ISR) and small vessel disease. Our objective was to evaluate the clinical efficacy of this strategy in a multicenter registry. METHODS Between 2009 and 2010 a prospective registry from two centers enrolled 156 consecutive patien...

An evaluation of drug eluting (coated) stents for percutaneous coronary interventions;